Share this Post!

The public is hereby informed that the Food and Drug Administration (FDA) has conducted sampling of specific batches of BRAVO Maca + Jatropha + Corynaea Crassa Food Supplement for Men as part of the strengthened post marketing surveillance of this Office.

The analyses of the FDA Laboratory showed that the aforementioned product under the specific lot number ABV38F26T and expiry date 26 February 2021 have tested positive for TadalafilTadalafil is a prescription drug used to treat male sexual function problems such as impotence or erectile dysfunction (ED).

Tadalafil is prohibited in food/dietary supplements, since it poses potential health risks to the unwary consuming public especially those who have had a stroke, severe vision loss, persons experiencing stomach ulcers, heart problems, kidney problems, liver problems, bleeding problem, blood cell problems, and low or high blood pressure. Possible side effects which can occur are as follows:

The presence of drug ingredient Tadalafil deems the food/dietary supplement as ADULTERATED, which is in violation of R.A. 9711 (FDA Act of 2009) and R.A. 10611, otherwise known as the Food Safety Act of 2013.

Consumers are advised to:

  1. Stop taking BRAVO Maca + Jatropha + Corynaea Crassa Food Supplement for Men with lot number ABV38F26T.
  1. Consult a healthcare professional in case you experience any of the side effects upon consumption of the product.
  1. Exercise caution when purchasing food supplements for men that can be potentially adulterated with drug ingredients which can seriously harm the consumers.

Further, the public who purchased BRAVO Maca + Jatropha + Corynaea Crassa Food Supplement for Men is advised to immediately coordinate with FDA at telephone number 857-1900 local 8105 or email us at [email protected]. To report continuous sale or distribution of unregistered health products, kindly email us at [email protected].

Attachment:->FDA Advisory No.2019-518